Zhitong Finance App News, Junshi Biotech (01877) issued an announcement. Due to career development reasons, Chen Yingge applied to resign as secretary of the company's board of directors, joint company secretary and authorized representative. The resignation took effect from the date it was delivered to the company's board of directors. After Chen Yingge's resignation, he will no longer hold any position in the company.

Furthermore, after the qualification review of the nomination committee of the third board of directors of the company, the company held the 30th meeting of the third board of directors on April 24, 2024 to review and pass the “Proposal on Appointing the Company's Board Secretary, Joint Company Secretary and Authorized Representative”. The details are as follows:

Wang Zhengyu was appointed as the secretary of the company's board of directors. The term of office is the same as the director of the third board of directors of the company. The appointment of Wang Zhengyu as the company's joint company secretary took effect from the date of review and approval at this board meeting; Wang Zhengyu was appointed to replace Chen Yingge as the company's authorized representative, effective from the date of review and approval at this board meeting.